Tweet
Here we go, typical summer thread for listing potential treatments in the future.
1. CB from Cosmo, poc finishes this fall and we should know results then or within 12 months of the trial finishing, they plan to release CB in 2021
2. SM, just came out of nowhere this last year, they finish a massive phase II dose ranging study this fall as well, we should know results within 12 prior.
3. Bim, no one knows what is going on, but they are forced to release results 12 months after the conclusion of the trial so we should know the results by January at the latest.
4. Histogen, in series D financing, I'd say it's safe to say they're dead and just haven't admitted it yet.
5. Replicel, getting everything postponed, they aim to start phase IIb dosing the end of this year or beginning of the next. Shiseido should be starting their own trials using the replicel technology this year though, could be released in Asia in 2018-2019
6. Kythera's setipiprant, was work from Dr. Cots at Penn, their company was recently acquired by Allergen, so who knows if this will be delayed but they aim to start poc trials early 2016
7. Dr. Cole is doing a research study that has just started on various techniques for PRP therapy
8. Dr. Wesley just began phase testing of 100-200 grafts using his Piloscopic device
Overall, it will be probably 5 years before we see one of these drugs hit the market, but we have more players in the game right now than ever. In the short term, hopefully Dr. Cole can prove there is some merit to these PRP techniques and hopefully Dr. Wesley can begin using his instrument in practice, and getting regeneration with it.
1. CB from Cosmo, poc finishes this fall and we should know results then or within 12 months of the trial finishing, they plan to release CB in 2021
2. SM, just came out of nowhere this last year, they finish a massive phase II dose ranging study this fall as well, we should know results within 12 prior.
3. Bim, no one knows what is going on, but they are forced to release results 12 months after the conclusion of the trial so we should know the results by January at the latest.
4. Histogen, in series D financing, I'd say it's safe to say they're dead and just haven't admitted it yet.
5. Replicel, getting everything postponed, they aim to start phase IIb dosing the end of this year or beginning of the next. Shiseido should be starting their own trials using the replicel technology this year though, could be released in Asia in 2018-2019
6. Kythera's setipiprant, was work from Dr. Cots at Penn, their company was recently acquired by Allergen, so who knows if this will be delayed but they aim to start poc trials early 2016
7. Dr. Cole is doing a research study that has just started on various techniques for PRP therapy
8. Dr. Wesley just began phase testing of 100-200 grafts using his Piloscopic device
Overall, it will be probably 5 years before we see one of these drugs hit the market, but we have more players in the game right now than ever. In the short term, hopefully Dr. Cole can prove there is some merit to these PRP techniques and hopefully Dr. Wesley can begin using his instrument in practice, and getting regeneration with it.
Comment